SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001467154-21-000131
Filing Date
2021-08-12
Accepted
2021-08-12 08:11:16
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20210812.htm   iXBRL 8-K 38298
2 EX-99.1 a08122021exhibit991.htm EX-99.1 90539
6 GRAPHIC novanlogoa06a.jpg GRAPHIC 10254
  Complete submission text file 0001467154-21-000131.txt   296961

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20210812.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20210812_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20210812_pre.xml EX-101.PRE 13037
7 EXTRACTED XBRL INSTANCE DOCUMENT novn-20210812_htm.xml XML 11338
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

IRS No.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 211165556
SIC: 2834 Pharmaceutical Preparations